Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Learn the scenarios where index funds outperform target date funds, with emphasis on fees, control, and asset allocation flexibility.
26,348 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
MiMedx (MDXG) 2025 earnings scrutiny goes beyond one quarter. This guide breaks down what to watch in the Q4 call, ho...
In June, SMCI faced a sharp 36% slide as investors weighed dilution, changing AI demand tides, and macro uncertainty....
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
July 2026 market conditions put a premium on true readiness. This report outlines eight signs you’re financially read...
When a notable small-cap manager exits a large stake in a data-security firm, it creates questions for investors. Thi...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
A bold HOA reform in Georgia aims to curb excesses, protect buyers, and sharpen lender risk assessments. This could c...